About the LKSIoV
The research interests of the Li Ka Shing Institute of Virology (LKSIoV) members encompass viral pathogenesis, vaccine development, correlates of immunity, enhancement of vaccine efficacy, oncolysis, and development of novel antivirals. Our members have made, and continue to make, a significant impact on human health around world.
Our Vision
Leading the world
in virology discoveries and cures.
Our Mission
Through leadership in scientific excellence and international collaboration, the Li Ka Shing Institute of Virology will invest in virology and immunology research to discover new methods to prevent, treat, and cure virus-related disease to reduce the burden of viral disease around the world.
Learn more about the Institute
Mandate
The LKSIoV unites a consortium of over 45 exemplary and world-renowned researchers to promote scientific advancements aimed at expanding our understanding of viruses and other selected pathogens, their respective disease pathogenesis, and host immune responses to such infections.
Founder + Director
D. Lorne Tyrrell is a Distinguished University Professor and GSK Chair in Virology at the University of Alberta. He is the Founding Director of LKSIoV.
Team
Meet the team behind the Li Ka Shing Institute of Virology.
Members
Most of LKSIoV's members are associated with the Department of Medical Microbiology & Immunology, with member affiliation encompassing 18 other units (institutes, departments, and faculties) at the University of Alberta. Other members are located in other Canadian institutions.
Partners + Connections
The LKSIoV collaborates with 68 international institutes, agencies, and networks in 23 countries around the world.